🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Joe Ensor

Natera (United States)

ORCID: 0000-0003-3533-4388
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “A Phase II Study of the Efficacy and Safety of Chloroquine in Combination With Taxanes in the Treatment of Patients With Advanced or Metastatic Anthracycline-refractory Breast Cancer”.

A Phase II Study of the Efficacy and Safety of Chloroquine in Combination With Taxanes in the Treatment of Patients With Advanced or Metastatic Anthracycline-refractory Breast Cancer

Clinical Breast Cancer(2020)10.1016/j.clbc.2020.09.015
N/A
0.604DataRank · unranked
55 citations

Polly Niravath, Tejal Patel, Joe Ensor, Angel Rodriguez, Toniva Boone +3 more

The value of interventional radiology in clinical trial teams: experience from the BATTLE lung cancer trials

Clinical Radiology(2020)10.1016/j.crad.2020.09.024
N/A
0DataRank · unranked
9 citations

Vassiliki A. Papadimitrakopoulou, Ignacio I. Wistuba, J.J. Lee, Joe Ensor, E.S. Kim +9 more

T-cell lymphoma secondary to checkpoint inhibitor therapy

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2019-000104
N/A
0DataRank · unranked
44 citations

Joe Ensor, Sai Ravi Pingali, Patrick Hwu, Madeleine Duvic, Stephen Chiang +4 more

Phase I/II study of azacitidine and capecitabine/oxaliplatin (CAPOX) in refractory CIMP-high metastatic colorectal cancer: evaluation of circulating methylated vimentin

UNC Libraries(2020)10.17615/kke1-de47
N/A
0DataRank · unranked
0 citations

Thomas LaFramboise, Michael S. Lee, Cathy Eng, David R. Fogelman, Stanley R. Hamilton +14 more

Data from 14-3-3ζ Overexpression Defines High Risk for Breast Cancer Recurrence and Promotes Cancer Cell Survival

(2023)10.1158/0008-5472.c.6499302.v1
N/A
0DataRank · unranked
0 citations

Jun Yao, Wentao Yang, Xiaoyan Zhou, Nina Nguyen, Jing Lu +8 more